↓ Skip to main content

Cochrane Database of Systematic Reviews

Pimozide for schizophrenia or related psychoses

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
twitter
10 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
271 Mendeley
Title
Pimozide for schizophrenia or related psychoses
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd001949.pub3
Pubmed ID
Authors

Meghana Mothi, Stephanie Sampson

Abstract

Pimozide, formulated in the 1960s, continues to be marketed for the care of people with schizophrenia or related psychoses such as delusional disorder. It has been associated with cardiotoxicity and sudden unexplained death. Electrocardiogram monitoring is now required before and during use.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 271 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 270 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 59 22%
Student > Bachelor 35 13%
Researcher 34 13%
Student > Ph. D. Student 31 11%
Student > Doctoral Student 18 7%
Other 47 17%
Unknown 47 17%
Readers by discipline Count As %
Medicine and Dentistry 83 31%
Psychology 42 15%
Nursing and Health Professions 31 11%
Social Sciences 16 6%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Other 30 11%
Unknown 57 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2017.
All research outputs
#1,493,074
of 18,771,444 outputs
Outputs from Cochrane database of systematic reviews
#3,639
of 11,857 outputs
Outputs of similar age
#17,243
of 199,102 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 112 outputs
Altmetric has tracked 18,771,444 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,857 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.4. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,102 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.